It has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...

As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...

Tamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...

Thailand plans to implement compulsory health insurance for all foreign visitors, including tourists and workers, to mitigate unpaid medica...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

Mark Cuban warns about US debt crisis: Cuban argues that overhauling healthcare, particularly insurance and drug pricing, can significantly...

Gilead said that it has also updated the pricing structure for drugs that it will be selling through its partner.

Olaizola, however, said the company is "working to ensure we comply with all orders issued by the NPPA regarding pricing of medicines."

As per the new drugs policy, all strengths and dosages specified in the National List of Essential Medicines (NLEM) 2011 will be under pric...

India's per capita public spending on health is an abysmal $32 or about Rs 1,800 per annum. The neediest of patients are often denied drugs...

Welcoming the government's draft proposal on drug pricing policy, the chemist body said the Centre should also decide the weighted average ...

The National Pharmaceutical Pricing Policy, 2011, seeks to evolve a formula to fix the maximum retail prices of 348 essential drugs.

A non-govt organisation campaigning for cheaper essential drugs has proposed an alternative pricing model that seeks to fix retail prices a...

Drug price regulator National Pharmaceutical Pricing Authority (NPPA) is set to become stronger, more transparent and receptive to industry...

Justifying government's decision to impose excise duty on medicines based on maxium retail price, PC said this would ensure transparency in...